Business Wire
Lilly diabetes drug slashes deaths 32 pct in heart-risk patientsReutersEli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in a study of 7,000 patients with type 2 diabetes at risk of heart attack and stroke, a finding that researchers said could make it a mainstay diabetes treatment. "This is the first ...Jardiance, a Diabetes Drug, Is Shown to Reduce Cardiovascular DeathsNew York TimesIn A First, A Diabetes Drug Saves Lives. But How?ForbesJardianceB. (empagliflozin) is the only diabetes medication to show a ...CNNMoneyWashington Timesall 7 news articles »
Thursday, September 17, 2015
Lilly diabetes drug slashes deaths 32 pct in heart
By
Unknown
On
9:12 AM
Subscribe to:
Post Comments (Atom)